CCMI
INDV icon

Creative Capital Management Investments’s Indivior Pharmaceuticals INDV Stock Holding History

Creative Capital Management Investments’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533 Buy
+13
New +$472 ﹤0.01% 1259

Other funds holding INDV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Creative Capital Management Investments's INDV Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 13 shares worth $533. The stake represents ﹤0.01% of the portfolio and ranks #1259 among its holdings.

49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Creative Capital Management Investments held 13 shares of Indivior Pharmaceuticals worth $533 as of Q2 2026.
  • Indivior Pharmaceuticals was a new Creative Capital Management Investments position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1259 holding.
  • 49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.